Jeff is a serial healthcare entrepreneur with over 20 years of pharmaceutical experience. Before taking over as TrialScope CEO in 2018, Jeff served on the Company’s Board of Directors for more than two years.

Prior to TrialScope, Jeff was the founder of two healthcare technology companies, HeroLinx and Verilogue. HeroLinx was an online crowdsourcing platform for accelerating clinical trial awareness and patient recruiting. Verilogue, which was acquired by Publicis (PUB:FP), is the global software leader in the capture and linguistic analysis of physician-patient exam room dialogues.

Jeff serves on the Board of Directors for three rapidly growing venture-backed companies: Analytical Wizards, Signallamp Health and Ripple Science. He also previously served on the Board of Directors for iContracts (acquired by RLDatix) and he remains an investor/advisor to other early-stage companies.

Jeff holds a BS in Economics from the Wharton School at the University of Pennsylvania, and is the co-author of a method and system patent for analyzing the effectiveness of marketing strategies.